Smoking history and tumor volume predict outcomes after CyberKnife head and neck reirradiation
In 36 previously irradiated head and neck cancer patients, CyberKnife SBRT achieved 55% one-year local control; smoking exposure predicted worse outcomes.
In 36 previously irradiated head and neck cancer patients, CyberKnife SBRT achieved 55% one-year local control; smoking exposure predicted worse outcomes.
Adding functional brain regions to CyberKnife optimization reduced dose to multiple structures by roughly 23%–39% while preserving target coverage.
Synthetic CT reproduced CyberKnife target dosimetry closely and enabled submillimetre translational image guidance, although rotational errors were more variable.
Tumour-size strata showed non-monotonic BED–control relationships, while machine-learning performance remained unvalidated outside a single retrospective centre.
CyberKnife improved conformity and reduced cardiac, pulmonary, and low-dose exposure, while noncoplanar linac techniques remained clinically acceptable alternatives.